StockData
Bone Biologics Corp logo

Bone Biologics Corp (BBLG) stock

BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)

Close on Nov 18, 2026Market cap $986.22KP/E –Yield –

Bone Biologics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Bone Biologics's revenue for the twelve months ending Jun 30, 2021 was $1.07B. For fiscal 2020 it was $1.07B, up 0.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2020Dec 31, 2020$1.07B0.0%
FY2019Dec 31, 2019$1.07B0.0%
FY2016Dec 31, 2016$1.07B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2021Jun 30, 2021$0–
Q1 FY2021Mar 31, 2021$1.07B0.0%
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$1.07B–

More Bone Biologics figures

See a number that looks wrong?